Cryptosporidium hominis: Difference between revisions

From IDWiki
Cryptosporidium hominis
(: added subpopulations)
(added Dx and Mx sections)
Line 2: Line 2:
* Similar to [[Cryptosporidium parvum]] which typically infects cows, but can also infect humans
* Similar to [[Cryptosporidium parvum]] which typically infects cows, but can also infect humans


== Microbiology ==
== Background ==

=== Microbiology ===


* Protozoan parasite in the genus [[Cryptosporidium species|''Cryptosporidium'']]
* Protozoan parasite in the genus [[Cryptosporidium species|''Cryptosporidium'']]


== Epidemiology ==
=== Epidemiology ===


* Infects humans, but can also infect cows, mice, gnotobiotic pigs, and rarely other species
* Infects humans, but can also infect cows, mice, gnotobiotic pigs, and rarely other species
Line 16: Line 18:
** Causes 2-6% of traveller's diarrhea
** Causes 2-6% of traveller's diarrhea


== Life Cycle ==
=== Life Cycle ===


* Host ingests an '''oocyst''' (needing as few as 10 to cause disease)
* Host ingests an '''oocyst''' (needing as few as 10 to cause disease)
Line 29: Line 31:
* Oocysts may be involved in auto-inoculation (if thin-walled) or environmental contamination (if thick-walled)
* Oocysts may be involved in auto-inoculation (if thin-walled) or environmental contamination (if thick-walled)


== Pathophysiology ==
=== Pathophysiology ===


* Infection activates nuclear factor kappa B (NF-κB), which activates a large response
* Infection activates nuclear factor kappa B (NF-κB), which activates a large response
Line 60: Line 62:
* May also involve extraintestinal cryptosporidiosis, such as biliary or respiratory disease
* May also involve extraintestinal cryptosporidiosis, such as biliary or respiratory disease


=== Other immunocompromised patients ===

* May present similarly to HIV
* Includes solid organ transplant, hematopoietic stem cell transplant, and hyper-IgM syndrome

== Diagnosis ==

* Stool antigen
* Stool with immunofluorescence or with acid-fast staining (70% sensitive)
* PCR

== Management ==

* Supportive care, including fluids and antimotility agents like loperamide
* In immunocompetent hosts: [[Is treated by::nitazoxanide]] 500 mg po tid for 3 days
* In severely immunocompromised patients, may not be curable without reversing immunosuppression


{{DISPLAYTITLE:''Cryptosporidium hominis''}}
{{DISPLAYTITLE:''Cryptosporidium hominis''}}

Revision as of 23:15, 9 October 2019

Background

Microbiology

Epidemiology

  • Infects humans, but can also infect cows, mice, gnotobiotic pigs, and rarely other species
  • Transmitted fecal-oral via environmental contamination (such as recreational water), and can be spread person-to-person
    • Outbreaks are most commonly associated with drinking water, even when properly treated
  • Resistant to chlorination and can survive in the environment up to 6 months
  • In developing countries, primarily affects children less than 5 years
  • In developed countries, primarily affects adults, related to travel
    • Causes 2-6% of traveller's diarrhea

Life Cycle

  • Host ingests an oocyst (needing as few as 10 to cause disease)
  • The oocyst excyst in the stomach and proximal small bowel, releasing four sporozoites
  • Sporozoites bind to the intestinal epithelial cells and becomes vacuolized by the host cell membrane
  • In the parasitophorous vacuole, they reproduce asexually into further sporozoites, which divide into type I meronts
  • The type I meronts mature and release motile merozoites
  • The merozoites again attach to the intestinal epithelial cells
  • Merozoites then either reproduce asexually, as above, or sexually
    • Sexual reproduction involves a macrogamont and microgamont, which form a zygote
    • The zygote develops into an oocyst which contains four sporozoites
  • Oocysts may be involved in auto-inoculation (if thin-walled) or environmental contamination (if thick-walled)

Pathophysiology

  • Infection activates nuclear factor kappa B (NF-κB), which activates a large response
  • Infection results in increased permeability of the intestinal mucosa
  • T-cells are involved, with chronic infection in patients who are CD4-deplete

Clinical Presentation

  • Incubation period 7 days (range 1 to 30 days)

Immunocompetent adults

  • Associated with waterborne outbreaks, travel, animal contacts, or child contacts
  • Watery (to mucoid) diarrhea and malabsorption
  • May also have abdominal cramping, nausea or vomiting, and fever
  • Lasts 5 to 14 days, but up to 100
  • However, recurs in about 40% and can become an intermittent or chronic diarrhea similar to irritable bowel syndrome

Childhood diarrhea

  • Causes about 10-15% of acute childhood diarrhea in developing countries
  • Presents with watery diarrhea, cramps, and nausea and vomiting
  • May also have fever, cough, dyspnea, and foul-smelling stool
  • Can turn into chronic diarrhea and malabsorption

People living with HIV

  • Most cases are asymptomatic or mild and self-limited
  • Chronic infection more common in HIV with CD4 <150, lasting up to 6 months
  • May also involve extraintestinal cryptosporidiosis, such as biliary or respiratory disease

Other immunocompromised patients

  • May present similarly to HIV
  • Includes solid organ transplant, hematopoietic stem cell transplant, and hyper-IgM syndrome

Diagnosis

  • Stool antigen
  • Stool with immunofluorescence or with acid-fast staining (70% sensitive)
  • PCR

Management

  • Supportive care, including fluids and antimotility agents like loperamide
  • In immunocompetent hosts: nitazoxanide 500 mg po tid for 3 days
  • In severely immunocompromised patients, may not be curable without reversing immunosuppression